UnknownNot Applicable

Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis

200 participantsStarted 2018-01-01

Plain-language summary

This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the severity of SAP, of course the clinical outcomes. The investigators want to find some biomarkers and strategy target drugs of severe acute pancreatitis.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of Severe Acute Pancreatitis * Biliary pancreatitis * 7 days of the onset Exclusion Criteria: * Surgical patients * Serious diseases and infection * Alcoholic pancreatitis * Hypertriglyceridemia pancreatitis * Disorder of Glucolipide Metabolism：diabetes mellitus, hypertriglyceridemia, BMI\>30

What they're measuring

mortality

Timeframe: up to 28 days

Trial details

NCT IDNCT03364920

SponsorWeiqin Li

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-01-01

Contact for this trial

Weiqin Li

13962531994 luyingying126@sina.cn

View on ClinicalTrials.gov More Pancreatitis, Acute trials